BioXcellerator
2015
FOUNDED
PRIVATE
STATUS
PE Growth
LATEST DEAL TYPE
$500K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Operator of stem cell therapy services. The company offers therapies and skin care creams which are used for various problems such as sports and orthopedic injuries, anti-aging and cosmetic treatments, life-threatening and debilitating diseases such as alzheimer's disease, diabetes and leukemia.
Website
Formerly Known As
Bioscience Americas, LLC
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 2122 East Highland Avenue
- Suite 265
- Phoenix, AZ 85016
- United States
+1 (888) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioXcellerator’s full profile, request a free trial.
BioXcellerator Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. PE Growth/Expansion | 29-Oct-2018 | $500K | 00.000 | Completed | Generating Revenue | |
| 1. Angel (individual) | 26-Oct-2017 | 00.000 | 00.000 | Completed | Generating Revenue |
BioXcellerator Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Shift4 Capital | Merchant Banking Firm | Minority | 000 0000 | 000000 0 |
BioXcellerator Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Eric Stoffers | Chief Executive Officer | ||
| Juan Galan | Chief Financial Officer | ||
| Ben Smith | Chief Operating Officer & Chairman | ||
| Matthew Marks | Chief Strategy Officer |
BioXcellerator Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ben Smith | BioXcellerator | Chief Operating Officer & Chairman | 000 0000 |